Table 2.
Stages | Genotype | No. of mice | VSD | Hypertrabeculation | Thin myocardium |
---|---|---|---|---|---|
E15.5–E19.5 | Control (+/+;f/f) | 10 | 0 | 0 | 0 |
Jarid2Nkx (C/+;f/f) | 11 | 10 (91%) | 9 (82%) | 8 (73%) | |
Nkx2.5-Cre (C/+;+/+) | 7 | 0 | 0 | 0 | |
Heterozygous (C/+;f/+) | 7 | 1 (14%) | 1 (14%) | 1 (14%) |